Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations

24 May 2021

Abstract excerpt

Coronavirus disease-19 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), represents one of the biggest challenges of 21st century, threatening public health around the globe. Increasing age and presence of co-morbidities are reported risk factors for severe disease and mortality, along with autoimmune diseases (ADs) and immunosuppressive treatments such as haematopoietic stem...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune and Inflammatory Disorders Research
Share to Hematopoietic Stem Cell Transplantation
Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34031556
DOI: 10.1038/s41409-021-01326-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendationsPMID 34031556Read ↗

Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseasesSemantic proximity Read ↗

Advances in hematopoietic stem cell transplantation for autoimmune diseasesSemantic proximity Read ↗

Crucial Aspects of the Management of Solid Organ Transplant Patient with COVID-19: A Narrative ReviewSemantic proximity Read ↗

Spotlight on the impact of viral infections on Hematopoietic Stem Cells (HSCs) with a focus on COVID-19 effectsSemantic proximity Read ↗

Clinical Presentations and Outcomes in Transplant Patients With COVID-19: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

COVID-19 Impact in Crohn’s Disease Patients Submitted to Autologous Hematopoietic Stem Cell Transplantation*Semantic proximity Read ↗

Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric PatientsSemantic proximity Read ↗

Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registrySemantic proximity Read ↗

American Society for Transplantation and Cellular Therapy Series #11: Updated Cytomegalovirus Guidelines in Hematopoietic Cell Transplant and Cellular Therapy RecipientsSemantic proximity Read ↗

Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies CommitteeSemantic proximity Read ↗

COVID-19 Impact in Crohn’s Disease Patients Underwent Autologous Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

UNVACCINATED PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES HAVE HETEROGENEOUS AND UNRELATED RISKS OF COVID INFECTION AND POOR OUTCOMESemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.